BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 195726)

  • 21. Some biochemical characteristics of rodent and human mammary carcinomas.
    Hilf R; Goldenberg H; Bell C; Michel I; Orlando RA; Archer FL
    Enzymol Biol Clin (Basel); 1970; 11(1):162-76. PubMed ID: 4313121
    [No Abstract]   [Full Text] [Related]  

  • 22. [The status of steroid receptors and hormone response in 7,12-dimethylbenz (a) anthracene (DMBA) induced rat mammary tumor].
    Zhang HY; Liu MS; Wang XM; Li SH; Hu C
    Shi Yan Sheng Wu Xue Bao; 1985 Jun; 18(2):225-30. PubMed ID: 3012916
    [No Abstract]   [Full Text] [Related]  

  • 23. [Estradiol receptors in the plasma membranes of cells in hormone-dependent mammary tumors].
    Morozova TM; Volchkov VE; Merkulova TI; Nagibneva IN
    Dokl Akad Nauk SSSR; 1983; 272(6):1494-7. PubMed ID: 6418499
    [No Abstract]   [Full Text] [Related]  

  • 24. Characterization of estradiol, progesterone, and prolactin receptors in nitrosomethylurea-induced mammary tumors and effect of antiestrogen treatment on the development and growth of these tumors.
    Turcot-Lemay L; Kelly PA
    Cancer Res; 1980 Sep; 40(9):3232-40. PubMed ID: 6253058
    [No Abstract]   [Full Text] [Related]  

  • 25. MXT mammary tumor treated by low dose chemotherapy. A 31P-NMR and 1H-MRI study.
    Scheiber C; Kiss R; De Launoit Y; Frühling J
    Anticancer Res; 1988; 8(3):403-7. PubMed ID: 2839100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of hormone-receptor interactions by means of fluorescence labeling.
    Dandliker WB; Brawn RJ; Hsu ML; Brawn PN; Levin J; Meyers CY; Kolb VM
    Cancer Res; 1978 Nov; 38(11 Pt 2):4212-24. PubMed ID: 212190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of pharmacological doses of estrogen on ovary-independent rat mammary carcinoma containing estrogen and progesterone receptors.
    Yoshida H; Fukuhara T; Yamashi S; Yoshida A; Fukunishi R; Tsuji M; Matsumoto K
    Cancer Res; 1983 May; 43(5):2311-6. PubMed ID: 6403234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor.
    Ip MM; Milholland RJ; Rosen F; Kim U
    Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and estrogen stimulation of cytoplasmic progesterone receptor in the ovarian-dependent MXT-3590 mammary tumor line.
    Watson CS; Medina D; Clark JH
    Cancer Res; 1979 Oct; 39(10):4098-104. PubMed ID: 476646
    [No Abstract]   [Full Text] [Related]  

  • 30. Androgen control of cytosol progesterone receptor levels in the MT-W9B transplantable mammary tumor in the rat.
    Ip MM; Milholland RJ; Kim U; Rosen F
    J Natl Cancer Inst; 1982 Sep; 69(3):673-81. PubMed ID: 6955558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Possible heterogeneity of cytoplasmic estrogen receptors].
    Alekseeva ML; Minina LS; Novikov EA; Shchedrina RN; Fanchenko ND
    Vopr Med Khim; 1984; 30(5):62-5. PubMed ID: 6528522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
    Tsai TL; Katzenellenbogen BS
    Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid receptor forms and their interaction with cytoplasmic modulators.
    Sato B; Nishizawa Y; Maeda Y; Noma K; Honma T; Matsumoto K
    J Steroid Biochem; 1983 Jul; 19(1A):315-21. PubMed ID: 6887866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steroid hormone receptors in mammary carcinoma: the effect of tamoxifen.
    Koenders AJ; Beex LV; Geurts-Moespot J; Benraad TJ
    Eur J Cancer (1965); 1980; Suppl 1():63-6. PubMed ID: 7318871
    [No Abstract]   [Full Text] [Related]  

  • 35. Synergistic effects of androgen and estrogen on the mouse uterus and mammary gland.
    Zhang J; Sun Y; Liu Y; Sun Y; Liao DJ
    Oncol Rep; 2004 Oct; 12(4):709-16. PubMed ID: 15375489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoplasmic estrogen receptor in a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous lines.
    Matsuzawa A; Mizuno Y; Yamamoto T; Hori T; Suzuki T
    Cancer Res; 1980 Sep; 40(9):3361-8. PubMed ID: 7427949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative analysis of the interaction of various estrogens with the estrogen-receptor system of the uterus].
    Fanchenko ND; Alekseeva ML; Minina LS; Novikov EA; Khel'mun DK
    Biokhimiia; 1985 Nov; 50(11):1853-8. PubMed ID: 4063405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammary cancer: selective action of the estrogen receptor complex.
    Ip M; Milholland RJ; Rosen F; Kim U
    Science; 1979 Jan; 203(4378):361-3. PubMed ID: 760195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ether-catalyzed dissociation rate of estradiol-receptor complex distinguishes between hormone-sensitive and resistant rat mammary tumors.
    Hollander VP; Khan S
    J Steroid Biochem; 1980 Jan; 12():131-4. PubMed ID: 6252377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.